Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chunduo Shen

Turoctocog Alfa Pegol Provides Effective Management for Major and Minor Surgical Procedures in Patients Across All Age Groups With Severe Haemophilia A: Full Data Set From the Pathfinder 3 and 5 Phase III Trials

Haemophilia

English

Related publications

Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)

Journal of Thrombosis and Haemostasis

Medicine

Hematology

2019

English

Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial

English

Measuring the Quality of Haemophilia Care Across Different Settings: A Set of Performance Indicators Derived From Demographics Data

English

Cardiovascular Risks, Bleeding Risks, and Clinical Events From 3 Phase III Trials of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

English

Major Surgery Management in Patients With Haemophilia a and Inhibitors on Emicizumab Prophylaxis Without Global Coagulation Monitoring

British Journal of Haematology

Hematology

2020

English

Preoperative A1C and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical Procedures

English

Inhibitor Development in Non-Severe Haemophilia Across Europe

Thrombosis and Haemostasis

Hematology

2015

English

Improvement of Atopic Dermatitis With Dupilumab Occurs Equally Well Across Different Anatomic Regions: Data From Phase 3 Clinical Trials

British Journal of Dermatology

Dermatology

Medicine

2019

English

Surgical Results of Major and Minor Laparoscopic Hepatectomies

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chunduo Shen

Turoctocog Alfa Pegol Provides Effective Management for Major and Minor Surgical Procedures in Patients Across All Age Groups With Severe Haemophilia A: Full Data Set From the Pathfinder 3 and 5 Phase III Trials

Related publications

Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)

Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial

Measuring the Quality of Haemophilia Care Across Different Settings: A Set of Performance Indicators Derived From Demographics Data

Cardiovascular Risks, Bleeding Risks, and Clinical Events From 3 Phase III Trials of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Major Surgery Management in Patients With Haemophilia a and Inhibitors on Emicizumab Prophylaxis Without Global Coagulation Monitoring

Preoperative A1C and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical Procedures

Inhibitor Development in Non-Severe Haemophilia Across Europe

Improvement of Atopic Dermatitis With Dupilumab Occurs Equally Well Across Different Anatomic Regions: Data From Phase 3 Clinical Trials

Surgical Results of Major and Minor Laparoscopic Hepatectomies